Quick Takeaways
- Iroquois Capital Management, LLC filed SCHEDULE 13G/A for Clearmind Medicine Inc. Common Stock, no par value (CMND).
- Disclosed ownership: 9.9%.
- Date of event: 30 Sep 2025.
Iroquois Capital Management, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Clearmind Medicine Inc. Common Stock, no par value (CMND)
- Filing Manager
- Iroquois Capital Management, LLC
- Reporting Manager
- Richard Abbe
- Symbol
- CMND
- Shares outstanding
- 6,071,127 shares
- Disclosed Ownership
- 603,470 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 18 Nov 2025, 06:50:20 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Iroquois Capital Management, LLC disclosed 9.9% ownership in Clearmind Medicine Inc. Common Stock, no par value (CMND) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 18 Nov 2025, 06:50.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Iroquois Capital Management, LLC | 5.4% | 310,990 | 0 | 310,990 | /s/ Richard Abbe | Richard Abbe, President | |
| Richard Abbe | 9.9% | 603,470 | 292,480 | 310,990 | /s/ Richard Abbe | Richard Abbe | |
| Kimberly Page | 5.4% | 310,990 | 0 | 310,990 | /s/ Kimberly Page | Kimberly Page |